The decision is about the lesion, not the diagnosis alone
A referral for ESD does not begin with a diagnosis label. It begins with a specific lesion that has been seen, sampled and, where relevant, staged. Two patients with the same diagnosis can reach different conclusions because depth of invasion, size, location, surface pattern and lymph-node risk differ.
ESD removes a piece of the gastrointestinal lining, including the submucosal layer beneath it, using an electrosurgical knife passed through an endoscope. It is a technique for superficial disease. It is not a treatment for a tumour that has grown through the muscle layer or has already spread to lymph nodes, and it is not a substitute for surgery in those settings.
That is why the useful question is not simply "do I qualify for ESD?" but "what does my lesion look like, what does the pathology show, and what would each option achieve?"
Where ESD is typically weighed against alternatives
Guidance from major gastrointestinal endoscopy bodies describes ESD as an option for certain early cancers and premalignant lesions of the oesophagus, stomach and colorectum. The common thread is a lesion that is superficial, accessible and judged to carry a low probability of nodal metastasis. Within that broad frame, the criteria are organ-specific and detailed.
For early gastric cancer, Japanese Gastric Cancer Association guidelines define absolute and expanded indications based on tumour size, histology, depth of submucosal invasion, absence of lymphovascular involvement and clear margins. These criteria are used internationally as a reference point, but a treating team applies them to the individual lesion and its full pathology.
For the oesophagus, superficial squamous neoplasia confined to the mucosa is a setting in which endoscopic resection is considered, with depth and circumferential extent influencing the choice between ESD and other resection methods. For the colorectum, large laterally spreading lesions and lesions suspected of shallow submucosal invasion may be considered for ESD, particularly when en bloc removal would be difficult by snare polypectomy.
Barrett's oesophagus with early neoplasia is another context, where ESD may be considered for selected lesions, sometimes alongside other resection techniques. In every case, the alternative may be surgery, another endoscopic method, or close surveillance, depending on what the team judges safest.
What the review actually looks at
A clinician considering ESD is assembling a risk picture. The first element is the endoscopic appearance: the size, location, morphology and surface or vascular pattern of the lesion under white light and, where available, image-enhanced endoscopy. These features inform the suspicion of depth.
The second element is histology. A biopsy provides the diagnosis and histological type, but it samples only part of the lesion. The final depth and margin status are usually established only after the resected specimen is examined. This is a key limitation to discuss: a plan based on biopsy and imaging is a prediction, and the definitive answer may change management after ESD.
The third element is staging. Where there is concern about deeper invasion or nodal spread, the team may use endoscopic ultrasound, cross-sectional imaging or other assessments. The exact tests are a clinical decision, not a fixed checklist that every patient must complete.
The fourth element is the patient. Age, other medical conditions, anticoagulant or antiplatelet use, previous surgery or scarring in the area, and the ability to undergo sedation or anaesthesia all affect whether ESD is reasonable and how it should be planned.
Records that make a remote review possible
For an overseas patient, the quality of the records often determines how useful a preliminary opinion can be. The endoscopy report matters most, including lesion location, size, morphology and the endoscopist's description of the surface. Clear images or video clips from the procedure add information that a written report cannot convey.
The pathology report should include the histological type, grade where relevant, and any comment on invasion or sampling adequacy. If a biopsy was taken elsewhere, the slides or blocks may be requested for review. Staging scans and their reports are relevant when deeper disease is a concern. A current medication list, particularly anticoagulants, antiplatelets and diabetes medicines, belongs in the file because it affects procedural planning.
It is reasonable to send a short summary first and ask what else the receiving team needs. A missing document does not necessarily mean assessment must wait; it means the team should be told what is unavailable so the limits of any opinion are clear.
Questions worth asking before committing to a plan
The answers shape both the clinical decision and the practical arrangements. Ask whether the lesion meets recognised criteria for endoscopic resection, and on what evidence that judgement rests. Ask what the alternative would be if ESD is not advised, and what the alternative would be if the final pathology after ESD shows higher-risk features.
Ask who will perform the procedure and how the team handles lesions in difficult locations, since operator experience and lesion position both affect technical success and complication risk. Ask about the recognised risks of ESD, which include bleeding and perforation, and how this hospital manages them. Ask about sedation, anaesthesia and same-day discharge or admission, because these are local arrangements that vary.
Ask what follow-up surveillance is recommended after resection and who will coordinate it. If you are travelling to China for care, ask how results and follow-up instructions will be communicated to your home clinician. These are questions for the treating team, not things an editorial article can settle.
Planning care in China around an ESD decision
China has high-volume endoscopy centres, and ESD is performed at major tertiary hospitals. Availability at a particular hospital, the experience of a particular team and the pathway for international patients are things to confirm directly rather than assume. A hospital decides whether to accept a patient and whether ESD is appropriate; no coordination service can promise acceptance or a clinical outcome.
The practical route usually starts with a records-based review. ChinaSpecialistCare's free initial case review checks the available diagnosis, records and the patient's main question, identifies missing information and suggests a relevant next step. A proxy consultation, in which a doctor takes records to a hospital specialist while the patient remains at home, is optional and not a prerequisite for an appointment. Hospital consultation fees, tests and treatment are separate from coordination fees.
For the clinical background, the Endoscopic Submucosal Dissection reference page describes the procedure itself, and the Gastroenterology specialty page covers the wider service context. Neither replaces an individual assessment.
A sensible next step is to gather the endoscopy report, pathology report and any staging imaging, then send a brief summary with your main question. The team can tell you what is missing and whether a specialist review is worth arranging. Worsening symptoms such as bleeding, severe pain or inability to swallow need local urgent assessment rather than a planned overseas trip.
Sources & scope of this guide
References and official service information relevant to this guide.
- Gastroenterology
- Related treatment reference
- Endoscopic Submucosal Dissection (ESD) of the upper digestive tract - Leeds Teaching Hospitals NHS Trust
- Endoscopic Submucosal Dissection (ESD) for Colorectal Growths - North Tees and Hartlepool NHS Foundation Trust
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
